Cochrane · systematic review · CD009889

Nurse‐led titration of angiotensin converting enzyme inhibitors, beta‐adrenergic blocking agents, and angiotensin receptor blockers for people with heart failure with reduced ejection fraction

Driscoll, A, Currey, J, Tonkin, A, et al. · Cochrane Database of Systematic Reviews · 2015 · Cochrane Library

HeartAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
5
current version
GRADE rated
5
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 0 · 0%Low 1 · 20%Moderate 3 · 60%High 1 · 20%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Nurse‐led titration versus usual care for people with heart failure with reduced ejection fraction

Population: people with heart failure with reduced ejection fraction
5 questions
OutcomeEffectEvidenceStatus / GRADE
All‐cause hospital admissions
Nurse‐led titration vs usual care
RR 0.8 [0.72, 0.88]4 studies · 560 participantsHigh
Heart failure‐related hospital admissions
Nurse‐led titration vs usual care
RR 0.51 [0.36, 0.72]4 studies · 642 participantsModerate
Downgraded: risk of bias
All‐cause mortality
Nurse‐led titration vs usual care
RR 0.66 [0.48, 0.92]6 studies · 902 participantsModerate
Downgraded: risk of bias, imprecision
All‐cause event‐free survival
Nurse‐led titration vs usual care
RR 0.6 [0.46, 0.77]3 studies · 370 participantsModerate
Downgraded: risk of bias
Proportion reaching target dose of medications
Nurse‐led titration vs usual care
RR 1.99 [1.61, 2.47]5 studies · 966 participantsLow
Downgraded: risk of bias, imprecision